|
|
 |
Hallucinogens Screen - Expanded, Serum/Plasma Test (8755SP)
| Analysis Code |
8755SP |
| Test Name |
Hallucinogens Screen - Expanded, Serum/Plasma |
| Test Includes |
2,5-dimethoxy-4-iodophenethylamine [LC/TOF-MS], 2,5-dimethoxy-4-n-propylthiophenethylamine [LC/TOF-MS], 4-Bromo-2,5-Dimethoxyphenethylamine [LC/TOF-MS], 4-methylmethcathinone [LC/TOF-MS], 5-Methoxy-N,N-Diisopropyltryptamine [LC/TOF-MS], 8-bromo-2,3,6,7-benzo-dihydro-difuran-ethylamine [LC/TOF-MS], 8-bromo-benzodifuranyl-isopropylamine [LC/TOF-MS], Atropine [LC/TOF-MS], BDB [LC/TOF-MS], Bufotenine [LC/TOF-MS], Dextro / Levo Methorphan [LC/TOF-MS], Dimethyltryptamine [LC/TOF-MS], Ketamine [LC/TOF-MS], LSD [LC/TOF-MS], MBDB [LC/TOF-MS], MDA [LC/TOF-MS], MDMA [LC/TOF-MS], Mescaline [LC/TOF-MS], Methyltryptamine [LC/TOF-MS], N-BZP [LC/TOF-MS], Norketamine [LC/TOF-MS], Phencyclidine [LC/TOF-MS], Psilocin [LC/TOF-MS], Salvinorin B [LC/TOF-MS], Scopolamine [LC/TOF-MS], TFMPP [LC/TOF-MS] |
| Compound Synonym(s) |
1-(1,3-benzodioxol-5-yl)-N-methylbutan-2-amine
1-(1,3-benzodioxol-5-yl)butan-2-amine
1-Benzylpiperazine
2-CB
2C-B FLY
2C-I
2C-T-7
3-Trifluoromethylphenylpiperazine
Adam
BZP
Benzylpiperazine
Bromo-DragonFLY
DMT
Ecstasy
Eden
Foxy
Foxymethoxy
Ketalar®
Ketamine Metabolite
Lysergic Acid Diethylamide
MDMA Metabolite
Maldemar®
Mephedrone
Methylenedioxyamphetamine
Methylenedioxymethamphetamine
N-Benzylpiperazine
Nexus
PCP
Psilocybin Metabolite
Salvia
Transderm-V®
alpha-methyltryptamine
d,l-Hyoscyamine |
| Purpose |
Forensic Analysis, Exclusion Screen |
| Category |
Hypnotic, Sedative, Anesthetic, Stimulant, Anticholinergic, Poison, Antitussive, Hallucinogen, Anticholinergic |
| Method(s) |
High Performance Liquid Chromatography/Time of Flight-Mass Spectrometry (LC/TOF-MS) |
| Specimen Requirements |
7 mL Serum or Plasma |
| Transport Temperature |
Refrigerated |
| Specimen Container |
Plastic container (preservative-free) |
| Special Handling |
Glass containers are not acceptable. Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines. |
| Light Protection Required |
Yes |
| Stability |
Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined
Psilocin and bufotenine are tested and reported as qualitative results because these compounds have limited stability in all biological matrices. While a positive result is evidence of use or exposure, a negative results does not rule out use of these drugs. |
| Rejection Criteria |
Not received Light Protected. Glass container. Polymer gel separation tube (SST or PST). |
| Day(s) Test Set-up |
[LC/TOF-MS] Tuesday 5 days |
| Suggested CPT Code |
[LC/TOF-MS] 80100 |
Reflex Testing
(when required, addl' fee may apply) |
52180SP - Hallucinogens Confirmation (Qualitative), Serum/Plasma
52181SP - Ketamine and Metabolite Confirmation, Serum/Plasma
52182SP - MDMA and Metabolite Confirmation, Serum/Plasma
52183SP - Atropine Confirmation, Serum/Plasma
52184SP - N-Benzylpiperazine Confirmation, Serum/Plasma
52185SP - Dextro / Levo Methorphan Confirmation, Serum/Plasma
52186SP - LSD Confirmation, Serum/Plasma
52187SP - Mescaline Confirmation, Serum/Plasma
52188SP - Dimethyltryptamine Confirmation, Serum/Plasma
52189SP - Phencyclidine Confirmation, Serum/Plasma
52190SP - Salvinorin B Confirmation, Serum/Plasma
52191SP - Scopolamine Confirmation, Serum/Plasma
52192SP - 3-Trifluoromethylphenylpiperazine Confirmation, Serum/Plasma |
You are viewing Hallucinogens Screen - Expanded, Serum/Plasma Test (8755SP)
|